Publicaciones en colaboración con investigadores/as de Hospital de Gran Canaria Dr. Negrin (74)

2026

  1. Benefits of a comprehensive care model in patients with heart failure and anemia: UMIPIC program

    Revista Clinica Espanola

  2. Benefits of a comprehensive care model in patients with heart failure and anemia: UMIPIC program

    Revista clinica espanola, Vol. 226, Núm. 5, pp. 502538

  3. CEBPA-bZIP Mutations in AML Patients Treated With Non-Intensive Therapy: A Study by the Spanish PETHEMA Registry

    Hematological Oncology, Vol. 44, Núm. 1

  4. Impact of thrombosis on disease progression, cancer and mortality in patients with essential thrombocythemia and polycythemia vera

    Blood Cancer Journal

  5. Interlaboratory cross validation of acute myeloid leukemia fusion genes and mutational targets detected by PCR: Performance of PETHEMA central laboratories

    Leukemia Research, Vol. 160

  6. Oxygen saturation and mortality for acute pulmonary embolism: multinational retrospective cohort study

    eClinicalMedicine, Vol. 94

  7. Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication–Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study

    Journal of Clinical Oncology

  8. Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study

    American Journal of Hematology

  9. Response to therapy and prognosis according to molecular characterization in CALR-mutated essential thrombocythemia

    HemaSphere, Vol. 10, Núm. 3

  10. Unveiling CMV Risk Signatures After Allogeneic Stem Cell Transplantation Through Machine Learning Approaches: A Multicenter Analysis From the GETH-TC

    Journal of Medical Virology, Vol. 98, Núm. 3

2025

  1. A phase 2, multicenter, clinical trial of CPX-351 in older patients with secondary or high-risk acute myeloid leukemia: PETHEMA-LAMVYX

    Cancer, Vol. 131, Núm. 1

  2. Are There Gender Differences in the Benefits of Multidisciplinary Care in Patients with Heart Failure? Results from the UMIPIC Program

    Journal of Clinical Medicine, Vol. 14, Núm. 16

  3. Are children and adolescents living with HIV in Europe and South Africa at higher risk of SARS-CoV-2 and poor COVID-19 outcomes?

    Epidemiology and Infection, Vol. 153

  4. Autologous or Allogeneic Hematopoietic Stem Cell Transplantation as Front-Line Treatment for Adult Secondary Acute Myeloid Leukemia Patients: The PETHEMA Registry Experience

    Transplantation and Cellular Therapy, Vol. 31, Núm. 5, pp. 299.e1-299.e14

  5. Benefits of a comprehensive care model in patients with heart failure and chronic obstructive pulmonary disease: UMIPIC program

    Revista Clinica Espanola, Vol. 225, Núm. 1, pp. 1-8

  6. Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Results of the PETHEMA PCR-LMA Study

    Cancers, Vol. 17, Núm. 5

  7. Device-aided therapies (DATs) in Parkinson's disease (PD). The DATs-PD GETM Spanish Registry Protocol Study

    PLoS ONE, Vol. 20, Núm. 3 March

  8. Effectiveness and safety of levodopa–entacapone–carbidopa infusion in Parkinson disease: A real-world data study

    European Journal of Neurology, Vol. 32, Núm. 1

  9. Hypokalemia During Decongestion With Loop Diuretics and Hydrochlorothiazide, a Post Hoc Analysis of the CLOROTIC Trial

    Circulation: Heart Failure, Vol. 18, Núm. 9, pp. e012914

  10. Mechanical power is not associated with mortality in COVID-19 mechanically ventilated patients

    Annals of Intensive Care, Vol. 15, Núm. 1